Kyorin Pharmaceutical Co.,ltd.TSE: 4569

KYORIN Pharmaceutical: Strong profit growth this year, but next year's outlook signals a significant earnings decline

· Issued by Kyorin Pharmaceutical Co.,ltd.

Net sales and profits saw strong year-over-year growth, with operating profit more than doubling. However, guidance for the next fiscal year anticipates declines in sales and earnings, and a lower profit outlook.

Original document:

This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.